Basit öğe kaydını göster

dc.contributor.authorGuven, G.S
dc.contributor.authorKiliçaslan, A
dc.contributor.authorOz, S.G
dc.contributor.authorHaznedaroglu, I.C
dc.contributor.authorKirazli, S
dc.contributor.authorAslan, D
dc.contributor.authorSözen, T.
dc.date.accessioned2019-12-10T11:11:30Z
dc.date.available2019-12-10T11:11:30Z
dc.date.issued2006
dc.identifier.urihttps://doi.org/10.1177/1076029606291403
dc.identifier.urihttps://www.scopus.com/inward/record.url?eid=2-s2.0-33748741980&partnerID=40&md5=6ab7af02f031072603ce4bc9ba313365
dc.identifier.urihttp://hdl.handle.net/11655/14970
dc.relation.isversionof10.1177/1076029606291403
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleDecrements In The Thrombin Activatable Fibrinolysis Inhibitor (Tafi) Levels In Association With Orlistat Treatment In Obesity
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.relation.journalClinical and Applied Thrombosis/Hemostasis
dc.contributor.departmentİç Hastalıkları
dc.identifier.volume12
dc.identifier.issue3
dc.identifier.startpage364
dc.identifier.endpage368
dc.description.indexScopus


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster